Furthermore, individual patient characteristics, such as age, baseline renal function, and preexisting endocrine disorders, may influence the susceptibility to PD-1/PD-L1 inhibitor-induced hyponatremia. The gene discussed is PDCD1; the disease is Hyponatremia.